Barclays Issues Positive Forecast for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price target upped by Barclays from $14.00 to $20.00 in a research note issued to investors on Tuesday,Benzinga reports. Barclays currently has an equal weight rating on the stock.

Other analysts have also recently issued reports about the company. KeyCorp dropped their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd. Royal Bank Of Canada increased their target price on Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, February 26th. Guggenheim lowered their price target on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. Cantor Fitzgerald set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Finally, Jefferies Financial Group lowered shares of Acadia Healthcare to a “hold” rating in a research note on Thursday, January 22nd. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and a consensus price target of $21.15.

Acadia Healthcare Price Performance

ACHC opened at $22.99 on Tuesday. The company has a current ratio of 1.55, a quick ratio of 1.44 and a debt-to-equity ratio of 1.27. The company has a market cap of $2.12 billion, a price-to-earnings ratio of -1.88, a price-to-earnings-growth ratio of 7.92 and a beta of 0.74. The stock has a fifty day simple moving average of $15.17 and a two-hundred day simple moving average of $18.58. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $31.43.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The company had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. During the same period last year, the business earned $0.64 EPS. Acadia Healthcare’s quarterly revenue was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Research analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. increased its position in Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after acquiring an additional 3,815,471 shares during the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at about $47,960,000. Wellington Management Group LLP increased its position in shares of Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Abrams Bison Investments LLC lifted its stake in shares of Acadia Healthcare by 96.7% in the 2nd quarter. Abrams Bison Investments LLC now owns 3,580,000 shares of the company’s stock worth $81,230,000 after purchasing an additional 1,760,000 shares during the period. Finally, Invenomic Capital Management LP grew its position in Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after buying an additional 1,375,647 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.